UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035431
Receipt number R000040364
Scientific Title insulin injection new entry (IINE) trial
Date of disclosure of the study information 2019/01/04
Last modified on 2019/01/03 18:03:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

insulin injection new entry (IINE) trial

Acronym

IINE trial

Scientific Title

insulin injection new entry (IINE) trial

Scientific Title:Acronym

IINE trial

Region

Japan


Condition

Condition

type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) or once-daily second-generation basal insulin analogs in Japanese adults with type 2 diabetes

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

percent change in HbA1c

Key secondary outcomes

daily insulin requirement
hypoglycemic episodes
body mass index


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

once-daily insulin degludec/insulin aspart (IDegAsp)

Interventions/Control_2

once-daily second-generation basal insulin analogs

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Japanese insulin-naive adults with type 2 diabetes, aged more than 20 years with HbA1c more than 7% and a body mass index of less than 35 kg/m2.

Key exclusion criteria

Subjects with type 1 diabetes, secondary diabetes, severe renal disease, severe hepatic disease.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Seiya Shimoda

Organization

Prefectural University of Kumamoto

Division name

Faculty of Environmental and Symbiotic Sciences

Zip code


Address

3-1-100 Tsukide Higashi-ku, Kumamoto, Kumamoto 862-8502, Japan

TEL

+81-96-321-6691

Email

sshimoda@pu-kumamoto.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Seiya Shimoda

Organization

Prefectural University of Kumamoto

Division name

Faculty of Environmental and Symbiotic Sciences

Zip code


Address

3-1-100 Tsukide Higashi-ku, Kumamoto, Kumamoto 862-8502, Japan

TEL

+81-96-321-6691

Homepage URL


Email

sshimoda@pu-kumamoto.ac.jp


Sponsor or person

Institute

Prefectural University of Kumamoto

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 04 Month 27 Day

Date of IRB


Anticipated trial start date

2017 Year 06 Month 01 Day

Last follow-up date

2018 Year 08 Month 31 Day

Date of closure to data entry

2018 Year 08 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 01 Month 03 Day

Last modified on

2019 Year 01 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040364


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name